9 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 13 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 13 | Completed 9, Unknown 2, Not yet recruiting 1, Recruiting 1 |
Follow Acute Bronchitis: new trials by email Literature Review of Acute Bronchitis trials Research Report on Acute Bronchitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of Acute Bronchitis in Adult Patients Raphamin, Placebo - Bronchitis, Acute Bronchitis | Phase 3 | Recruiting | Materia Medica Holding | 308 | 2025-12-09 | 2026-06-29 |
| Efficacy and Safety of AG2001 in Patients With Acute Bronchitis AG2001, AG20011, AG20012 - Acute Bronchitis | Phase 3 | Not yet recruiting | Ahn-Gook Pharmaceuticals Co.,Ltd | 300 | 2025-11-01 | 2025-09-30 |
| Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis YHP2401, YHR2402, YHR2403 - Acute Bronchitis | Phase 3 | Completed | Yuhan Corporation | 286 | 2025-08-19 | 2026-02-09 |
| A Study to Evaluate the Efficacy and Safety of DW5121 Compared to DW51211 and DW51212 DW5121, DW51211, DW51212 - Acute Bronchitis | Phase 3 | Completed | Daewon Pharmaceutical Co., Ltd. | 273 | 2024-03-28 | 2025-07-30 |
| A Clinical Trial to Evaluate the Safety and Efficacy of "AG1904" in Acute Bronchitis AGS (Experimental), AGU (Active Comparator) - Acute Bronchitis | Phase 3 | Completed | Ahn-Gook Pharmaceuticals Co.,Ltd | 220 | 2019-10-17 | 2022-04-25 |
| Clinical Trial to Evaluate the Efficacy and Safety of 'DW1601' in Acute Bronchitis DW1601, DW16011, DW16012 - Acute Bronchitis | Phase 3 | Unknown | Daewon Pharmaceutical Co., Ltd. | 204 | 2018-12-20 | 2020-02-07 |
| Clinical Trials to Assess the Efficacy and Safety of HLIM Test, Active Comparator Control 1, Active Comparator Control 2 - Acute Upper Respiratory Tract Infection, Acute Bronchitis | Phase 3 | Unknown | SamA Pharmaceutical Co., Ltd | 487 | 2018-11-29 | 2019-02-08 |
| A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Umkamin Tab in Acute Bronchitis Patients HL301(Experimental), Umkamin(Active Comparator) - Acute Bronchitis | Phase 3 | Completed | Hanlim Pharm. Co., Ltd. | 246 | 2018-03-16 | 2019-02-12 |
| Compare the Efficacy and Safety of Surfolase CR Tablet With Surfolase Capsule in Patients With Acute Bronchitis Acebrophylline - Acute Bronchitis | Phase 3 | Completed | Hyundai Pharmaceutical Co., LTD. | 244 | 2015-11-01 | 2017-06-16 |
| Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life Vitamin D3, Placebo - Acute Bronchitis, Upper Respiratory Tract Infection | Phase 3 | Completed | Hospital Universitari Vall d'Hebron Research Institute | 200 | 2013-11-01 | 2017-03-22 |
| Safety and Efficacy of KALOMIN™ Tab. in Patients With Acute Bronchitis KALOMIN™ Tab., Umckamin syrup - Acute Bronchitis | Phase 3 | Completed | Korea United Pharm. Inc. | 242 | 2013-08-01 | 2014-05-30 |
| Clinical Trial to Evaluate the Safety and Efficacy of "Theobromine Capsule" as an Antitussive in Acute Cougher Theobromine 300mg, Levodropropizine 10mg - Acute Bronchitis | Phase 3 | Completed | Ahn-Gook Pharmaceuticals Co.,Ltd | 332 | 2010-05-01 | 2011-08-15 |
| A Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases Azithromycin SR - Acute Bronchitis | Phase 3 | Completed | Pfizer | 64 | 2006-10-01 | 2011-04-21 |
Bronchitis (13) · Cough (2) · Respiratory Tract Infections (2)
Bronchial Diseases (13) · Infections (13) · Lung Diseases (13) · Lung Diseases, Obstructive (13) · Respiratory Tract Diseases (13) · Respiratory Tract Infections (11) · Pathological Conditions, Signs and Symptoms (2) · Respiration Disorders (2) · Signs and Symptoms (2) · Signs and Symptoms, Respiratory (2)
Aspartylglucosylaminase (1) · Cholecalciferol (1) · Theobromine (1) · ambroxol-theophylline-7-acetate (1) · dipropizine (1)
Ahn-Gook Pharmaceuticals Co.,Ltd (3) · Daewon Pharmaceutical Co., Ltd. (2) · Hanlim Pharm. Co., Ltd. (1) · Hospital Universitari Vall d'Hebron Research Institute (1) · Hyundai Pharmaceutical Co., LTD. (1) · Korea United Pharm. Inc. (1) · Materia Medica Holding (1) · Pfizer (1) · SamA Pharmaceutical Co., Ltd (1) · Yuhan Corporation (1)
South Korea (7) · Japan (1) · Russia (1) · Spain (1)
Antonio Moreno, MD, PhD (1) · Jae Yeol Kim, M.D. (1) · Jaejeong Shim, Principal Investigator (1) · Ki-Suck Jung, M.D. (1) · Kwan Ho Lee, M.D. (1) · Soo-Taek Uh, M.D. (1) · Sung Soon Lee, M.D. (1) · Yong Bum Park, M.D. (1) · Young Kyoon Kim, M.D. (1)